封面
市場調查報告書
商品編碼
2039089

腸道傳染病檢查市場:依疾病類型和地區分類

Enteric Disease Testing Market, By Disease Type, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,腸道傳染病檢查市場規模將達到 51 億美元,到 2033 年將達到 78 億美元。預計從 2026 年到 2033 年,該市場將以 4.2% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 51億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 4.20% 2033年市場規模預測: 78億美元

腸道感染疾病( ETI)是一種腸道疾病,可引起多種症狀,從輕微的腸胃炎到全身性行為感染和嚴重腹瀉。根據世界衛生組織2017年的報告,感染性腸胃炎每年導致全球10億例腹瀉病例和200多萬人死亡。此外,比爾及梅琳達蓋茲基金會(2017年)的數據顯示,腸道感染疾病和腹瀉每年導致約50萬名五歲以下兒童死亡,而幼兒時期反覆感染腸道病原體的兒童可能會面臨終身健康問題。兒童腸道感染疾病的持續增加是推動腸道傳染病檢查市場成長的主要因素之一。此外,主要製造商不斷推出腸道傳染病檢查產品,預計也將促進預測期內的市場成長。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數分析了全球腸道傳染病檢查市場的主要參與者:公司概況、財務績效、產品系列、市場佔有率、分銷策略、關鍵發展、策略和未來計劃。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球腸道傳染病檢查市場》報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業利益相關相關人員。
  • 相關人員可以透過利用全球腸道傳染病檢查市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 影響分析
  • 主要亮點
  • 產品發布
  • PEST分析
  • 技術進步
  • 法規環境
  • 併購

第4章 全球腸道傳染病檢查市場:依疾病類型分類,2026-2033年

  • 大腸桿菌感染疾病
  • 沙門氏菌病
  • 曲狀桿菌感染
  • 輪狀病毒感染疾病
  • 隱孢子蟲病
  • 諾羅病毒感染疾病
  • 霍亂
  • 艱難梭菌
  • 幽門螺旋桿菌
  • 阿米巴病

第5章 全球腸道傳染病檢查市場:依地區分類,2026-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第6章 競爭情勢

  • 公司簡介
    • Alere, Inc
    • Becton Dickinson &Company
    • Biomerica, Inc
    • bioMerieux
    • Bio-Rad
    • Cepheid
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience, Inc.
    • Quest Diagnostics
    • Trinity Biotech

第7章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1164

Enteric Disease Testing Market is estimated to be valued at USD 5.1 Bn in 2026 and is expected to reach USD 7.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 5.1 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 4.20% 2033 Value Projection: USD 7.8 Bn

Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five each year, and children who survive repeated infections by gut pathogens in the early years of their life may suffer from lifelong health problems. This continuous rise in enteric infections among children is one of the major factors contributing to growth of the enteric disease testing market. Moreover, increasing launch of enteric disease testing products by key manufacturers is expected assist the growth of the market over the forecast period.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Enteric Disease Testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Enteric Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Enteric Disease Testing market

Market Segmentation

  • By Disease Type
    • E. coli Infection
    • Salmonellosis
    • Campylobacteriosis
    • Rotavirus Infection
    • Cryptosporidiosis
    • Norovirus Infection
    • Cholera
    • C. difficile
    • H. pylori
    • Amebiasis
    • Shigellosis
  • By Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Alere, Inc
    • Becton Dickinson & Company
    • Biomerica, Inc
    • bioMerieux
    • Bio-Rad, Cepheid
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience, Inc.
    • Quest Diagnostics
    • Trinity Biotech

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Disease Type
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Enteric Disease Testing Market, By Disease Type, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • E. coli Infection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Salmonellosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Campylobacteriosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Rotavirus Infection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cryptosporidiosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Norovirus Infection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cholera
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • C. difficile
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • H. pylori
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Amebiasis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Shigellosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Enteric Disease Testing Market, By Region, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • North America
    • Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026-2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026-2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026-2033, (USD Bn)
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026-2033, (USD Bn)
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026-2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Disease Type, 2026-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026-2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

6. Competitive Landscape

  • Company Profiles
    • Alere, Inc
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Becton Dickinson & Company
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Biomerica, Inc
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • bioMerieux
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio-Rad
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Cepheid
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Coris BioConcept
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • DiaSorin
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Meridian Bioscience, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Quest Diagnostics
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Trinity Biotech
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact